Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
REFERENCES Khadzhynov D, Slowinski T, Lieker I, et al, "Pharmacokinetics of Aliskiren in Patients With End-Stage Renal Disease Undergoing Haemodialysis," Clin Pharmacokinet , 2012, 51(10):661-9. [PubMed 23018529 ] Parving HH, Persson F, Lewis JB, et al, “Aliskiren Combined With Losartan in Type 2 Diabetes and Nephropathy,” N Engl J Med , 2008, 358(23):2433-46. [PubMed 18525041 ] Straessen JA, Li Y, and Richart T, “Oral Renin Inhibitors,” Lancet , 2006, 368(9545):1449-56. [PubMed 17055947 ] Vaidyanathan S, Bigler H, Yeh C, et al, “Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskerin Alone and in Combination with Irbesartan in Renal Impairment,” Clin Pharmacokinet, 2007, 46(8):661-75. [PubMed 17655373 ] Vaidyanathan S, Warren V, Yeh C, et al, “Pharmacokinetics, Safety, and Tolerability of the Oral Renin Inhibitor Aliskiren in Patients With Hepatic Impairment,” J Clin Pharmacol , 2007, 47(2):192-200. [PubMed 17244770 ] Topic 9282 Version 38.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0603-61.234.146.186-B3512DFB86-S244013.14]